Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04583839
Other study ID # STU00212306
Secondary ID 1R34DK125958
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2020
Est. completion date January 31, 2024

Study information

Verified date June 2024
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a pilot assessment of Sustaining Women's Engagement and Enabling Transitions after GDM (SWEET), a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with gestational diabetes mellitus. The investigators aim to determine, via a randomized controlled trial of 40 women who have had GDM, whether those who receive the navigation intervention have improved diabetes-related health at 1 year after birth compared to those who receive usual care. The SWEET intervention will provide GDM-specific, individualized navigation services that leverage existing clinical infrastructure, including logistical support, psychosocial support, and health education, through 1-year postpartum. Participants will undergo surveys, interviews, and medical record review at multiple time points. The investigators will also conduct qualitative interviews with clinical providers.


Description:

Gestational diabetes mellitus (GDM) poses a substantial long-term health burden to women due to the 7-fold increased risk of developing type 2 diabetes mellitus (T2DM) and other cardiovascular disorders. Yet, there are many gaps in the transition period after GDM, which is a particularly critical time due to enhanced motivation and access. Nevertheless, a minority of women receive postpartum screening for dysglycemia or have successful transition to primary care. Although T2DM prevention interventions can be successful, they cannot be deployed without retention and engagement in care. Addressing the unique barriers experienced by postpartum women requires innovative models of health care delivery to promote prevention of T2DM after GDM. One potential intervention with demonstrated successes in other arenas is patient navigation, a barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. This protocol is to perform a pilot assessment of Sustaining Women's Engagement and Enabling Transitions after GDM (SWEET), a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with GDM. The investigators aim to determine, via a randomized controlled trial of 40 women who have had GDM, whether those who receive the SWEET navigation intervention have improved diabetes-related health at 1 year after birth compared to those who receive usual care. In order to promote self-efficacy, enhance access, and sustain long-term engagement, the SWEET intervention will provide GDM-specific, individualized navigation services that leverage existing clinical infrastructure, including logistical support, psychosocial support, and health education, through 1-year postpartum. Aim 1 will evaluate whether clinical (weight, glycemic control, abdominal circumference, and blood pressure), health services (postpartum and primary care visit attendance), and patient-reported (diabetes self-efficacy, activation, and T2DM risk perception) outcomes differ in women exposed to SWEET versus usual care. Aim 2 will evaluate feasibility and acceptability. This proposal will generate key data for the conduct of a full-scale trial of a GDM-specific postpartum patient navigation program that will address critical questions about long-term maternal health and T2DM prevention. SWEET bridges the chasm between care during pregnancy - focused on improving the health of the pregnant woman and her offspring - and long-term women's health care - focused on chronic disease management and preventive health. The long-term goals are to understand how to optimize long-term health after GDM in order to prevent or ameliorate the effects of T2DM beyond the perinatal period.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 31, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers No
Gender Female
Age group 16 Years and older
Eligibility Patient Participants: Inclusion Criteria: - Pregnancy delivering at or after 30 weeks of gestation, regardless of neonatal outcome - Gestational diabetes mellitus, treatment of any modality - English- or Spanish- speaker - Age 16 or greater - Established patient at the Northwestern Medicine obstetrics and gynecology practices Exclusion Criteria: - Intent to transfer prenatal care to an outside institution or leave Chicago region - Pre-gestational diabetes mellitus - Weight loss during pregnancy - History of bariatric surgery - Prior enrollment in SWEET - Enrollment in a concurrent research study that poses a potential conflict to the aims of SWEET or the other study Health care provider participants: Inclusion Criteria: - Age 18 or greater - English-speaking - Obstetrician or advanced practitioner who has provided postpartum care to a participating SWEET participant OR primary care provider who has provided primary care to a participating SWEET participant

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Patient Navigation Program
SWEET is a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with GDM. Women in SWEET will receive GDM-specific, tapered, individualized navigation services, including logistical support, psychosocial support, and patient education, through 1-year postpartum.

Locations

Country Name City State
United States Northwestern Memorial Hospital Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
Northwestern University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Participant experiences and perspectives on GDM Qualitative feedback on experience with the GDM diagnosis, barriers to obtaining postpartum GDM-related care, and barriers and facilitators of the primary care transition. 4-12 weeks and 1 year postpartum
Other Patient experiences with navigation Participants who are randomized to receive navigation will complete in-depth interviews about experiences with the program and areas for improvement. 4-12 weeks and 1 year postpartum
Other Health care providers experiences with SWEET Health care providers whose patients participate in the trial will undergo in-depth interviews about provider perceptions of the program, barriers to providing optimal care for women who have had GDM, the methods by which providers and the health care system can adopt postpartum care recommendations, and how to optimize SWEET for future study. Through completion of study, an average of 2 years
Other Patient satisfaction with logistical aspects of navigation Patient Satisfaction with Logistical Aspects of Navigation (PSN-L)- Participants randomized to navigation will complete surveys designed to understand their logistical experiences with patient navigation. Minimum score is 0, and maximum score is 78. Higher scores indicate higher levels of satisfaction. 4-12 weeks and 1 year postpartum
Other Patient satisfaction with interpersonal relationship with navigator Patient Satisfaction with Interpersonal Relationship with Navigator (PSN-I)- Participants randomized to navigation will complete surveys designed to understand their interpersonal experiences with patient navigation. Minimum score is 0, and maximum score is 45. Higher scores indicate higher levels of satisfaction. 4-12 weeks and 1 year postpartum
Other Proportion of eligible participants who enroll Proportion of eligible participants who enroll will be defined as the proportion of women who enroll out of all approached, eligible women. Through completion of study, an average of 2 years
Other Recruitment rate Recruitment rate will be defined as the number of women successfully enrolled per week during the study, using mean or median to illustrate the variation of the numbers. Through completion of study, an average of 2 years
Other Time to enrollment Time to enrollment will be defined as the number of months to enroll target sample size. Through completion of study, an average of 2 years
Other Dropout rate Dropout rate will be defined as the number of enrolled women who drop out of study participation during the 1-year follow-up per week. Through completion of study, an average of 2 years
Other Retention rate Retention rate will be defined as the proportion of enrolled women who successfully complete all study visits during 1-year follow-up period. Through completion of study, an average of 2 years
Other Participant adherence with navigation The participant adherence (engagement rate) outcomes will be calculated both as a proportion (percent of navigator-attempted contacts with response) and count (number of navigator-attempted contacts with response) among participants randomized to navigation. Feasibility targets will be defined as 80% recruitment, retention, and adherence rates. Targets are set at 80% based on prior literature using this threshold to represent greater engagement. Through completion of study, an average of 2 years
Primary Postpartum weight retention Difference between 1) preconception weight and 2) weight at 1 year postpartum, 1 year postpartum
Secondary Postpartum diabetes screening completion Number of women with completion of a 2-hour oral glucose tolerance test by 12 weeks postpartum. 4-12 weeks postpartum
Secondary Postpartum diabetes screening result Result of postpartum OGTT. 4-12 weeks postpartum
Secondary Abdominal circumference Abdominal circumference at any time point in the first year after giving birth. 4-12 weeks and 1 year postpartum
Secondary Blood pressure Blood pressure at any time point in the first year after giving birth and proportion with hypertension. 4-12 weeks and 1 year postpartum
Secondary Postpartum visit attendance Attendance at a comprehensive postpartum care visit by 12 weeks postpartum. 4-12 weeks postpartum
Secondary Assessment of postpartum glycemic control Number of women who complete any measure of glycemic control (fasting glucose, random glucose, and/or hemoglobin A1c) by 1 year postpartum. 1 year postpartum
Secondary Postpartum transition to primary care Number of women with appointment made and kept for primary care by 1 year postpartum. 1 year postpartum
Secondary Diabetes self-efficacy Diabetes Empowerment Scale (DES)- Minimum score is 1, and maximum score is 5. Higher scores indicate greater levels of diabetes self-efficacy. 4-12 weeks and 1 year postpartum
Secondary Patient activation Patient Activation Measure (PAM)- Patient knowledge, skill, and confidence for managing one's own health and healthcare. Minimum score is 1, and maximum score is 100. Higher scores indicate higher activation levels in self-management. 4-12 weeks and 1 year postpartum
Secondary Diabetes risk perception Risk Perception Survey for Developing Diabetes (RPS-DD)- adapted for women with gestational diabetes- Scores are averaged with higher scores indicating a greater personal control to prevent development of DM. Minimum score of 1, and maximum score of 5. Higher scores indicate greater personal control beliefs. 4-12 weeks and 1 year postpartum
See also
  Status Clinical Trial Phase
Recruiting NCT05081037 - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) N/A
Active, not recruiting NCT03249896 - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes N/A
Terminated NCT03749889 - Low Carb vs Normal Carb in Pregnancy N/A
Completed NCT03859193 - Education Nutritional Video for Gestational Diabetics N/A
Recruiting NCT05037526 - Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes N/A
Completed NCT06178250 - Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester N/A
Not yet recruiting NCT06445530 - Nutrition Optimization and Community Upliftment for Postpartum Recovery N/A
Not yet recruiting NCT06310356 - Continuous Glucose Monitoring for Women With Gestational Diabetes N/A
Recruiting NCT02590016 - Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT00883259 - Metformin and Gestational Diabetes in High-risk Patients: a RCTs Phase 4
Withdrawn NCT01947699 - Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide Phase 4
Recruiting NCT03008824 - Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby N/A
Active, not recruiting NCT01340924 - Relationship Between Gestational Diabetes and Type 2 Diabetes
Completed NCT00534105 - Lipid Metabolism in Gestational Diabetes N/A
Recruiting NCT00371306 - Comparison of Glucovance to Insulin for Diabetes During Pregnancy N/A
Completed NCT03388723 - Intergenerational Programming of Diabesity in Offspring of Women With Gestational Diabetes Mellitus
Recruiting NCT04521712 - Postpartum Glycemia in Women at Risk For Persistent Hyperglycemia N/A
Enrolling by invitation NCT03307486 - Gestational Diabetes: a Cohort Study N/A
Active, not recruiting NCT03301792 - Group Versus Traditional Prenatal Care for Diabetes N/A
Enrolling by invitation NCT05603793 - YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition